Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Modulatory Effects of Korean Red Ginseng Extract (Panax ginseng C.A. Meyer) on Cytochrome P450 after Oral Administration to Mice for 14 Days

마우스에 홍삼추출물의 14일간 경구 투여에 따른 약물대사효소 조절능 평가

  • Kim, Hee-Yeon (College of Pharmacy, Kyungpook National University) ;
  • Nam, Woong-Shik (College of Pharmacy, Kyungpook National University) ;
  • Kim, Seong-Hee (College of Pharmacy, Kyungpook National University) ;
  • Jang, Hye-Ryang (College of Pharmacy, Kyungpook National University) ;
  • Lee, Mi-Kyoung (College of Pharmacy, Kyungpook National University) ;
  • Kim, Tae-Wan (Department of Physiology, College of Veterinary Medicine, Kyungpook National University) ;
  • Lee, Sang-Kyu (College of Pharmacy, Kyungpook National University)
  • Received : 2012.05.25
  • Accepted : 2012.08.01
  • Published : 2012.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

Ginseng is one of the most commonly used herbal medicines and health foods. Korean red ginseng (KRG; Panax ginseng C.A. Meyer) extract is known to have potential therapeutic activities, such as anti-viral effects, the amelioration of food allergies, anti-oxidant effects, and obesity reduction. Nevertheless, no reports have been issued the modulatory effects of KRG extract on the activity of cytochrome P450 (CYP). In the present study, we investigated the modulatory effect of KRG extract in vitro and in vivo by using pooled human liver microsomes and male ICR mice. When human liver microsomes were incubated with KRG extract at 0.01-10 mg/ml, CYP1A2, 2B6, 2C19, 2D6, and 3A were not significantly inhibited by KRG extract, although CYP2B6 was slightly inhibited. Mice were orally administered KRG extract at 50, 250, or 500 mg/kg daily for 3, 7, or 14 days. However, the activities of CYPs in mouse livers were not significantly different from those of vehicle-treated controls. In conclusion, no significant ginseng-drug interaction was observed. KRG extract did not significantly modulate the activities of CYPs in vitro or in vivo.

인삼 및 인삼 유래 물질들은 가장 대표적인 건강기능식품이며, 홍삼추출물(Panax ginseng C.A. Meyer)의 경우 항바이러스, 알레르기 감소, 항산화, 비만억제 등의 효과를 나타낸다고 알려져 있다. 대표적 건강기능식품임에도 불구하고 약물상호작용을 일으키는 대사효소(Cytochrome P450, CYP)에 대한 홍삼추출물의 영향은 보고되지 않았다. 본 연구에서는 사람의 간 마이크로좀 분획과 마우스 모델을 기반으로 홍삼엑기스의 약물대사 조절능을 평가하였다. 사람의 간 마이크로좀에서는 CYP2B6에 대한 미약한 억제 효과를 나타내었을 뿐, 타 대사효소 CYP1A2, 2B6, 2C19, 2D6와 3A에 대한 억제효과는 검출되지 않았다. 홍삼엑기스를 마우스에 50, 250, or 500 mg/kg의 농도로 3, 7, 14일간 하루 1회 경구 투여 후 간을 적출하여 대사효소의 활성 변화를 측정하였지만, 유의적인 변화는 관찰되지 않았다. 결과적으로 홍삼엑기스의 유의적인 약물대사효소에 대한 활성 조절능이 없는 것으로 판단되고, 홍삼엑기스 복용에 따른 홍삼-약물상호작용의 가능성은 없을 것으로 추정된다.

Keywords

References

  1. Boyne, A. F. and Ellman, G. L. 1972. A methodology for analysis of tissue sulfhydryl components. Anal. Biochem. 46, 639-653. https://doi.org/10.1016/0003-2697(72)90335-1
  2. Chang, T. K., Chen, J. and Benetton, S. A. 2002. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1. Drug Metab. Dispos. 30, 378-384. https://doi.org/10.1124/dmd.30.4.378
  3. Ha, K. C., Kim, M. G., Oh, M. R., Choi, E. K., Back, H. I., Kim, S. Y., Park, E. O., Kwon, D. Y., Yang, H. J., Kim, M. J., Kang, H. J., Lee, J. H., Choi, K. M., Chae, S. W. and Lee, C. S. 2012. A placebo-controlled trial of Korean red ginseng extracts for preventing Influenza-like illness in healthy adults. BMC Complement Altern. Med. 12, 10. https://doi.org/10.1186/1472-6882-12-10
  4. Han, M. and Fang, X. L. 2006. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models. Acta Pharmacol. Sin. 27, 499-505. https://doi.org/10.1111/j.1745-7254.2006.00303.x
  5. Hao, M., Ba, Q., Yin, J., Li, J., Zhao, Y. and Wang, H. 2011. Deglycosylated ginsenosides are more potent inducers of CYP1A1, CYP1A2 and CYP3A expression in HepG2 cells than glycosylated ginsenosides. Drug. Metab. Pharmacokinet. 26, 201-205. https://doi.org/10.2133/dmpk.DMPK-10-NT-056
  6. Henderson, G. L., Harkey, M. R., Gershwin, M. E., Hackman, R. M., Stern, J. S. and Stresser, D. M. 1999. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci. 65, 209-214.
  7. Kim, H., Lee, S. G., Chae, I. G., Kim, M. J., Im, N. K., Yu, M. H., Lee, E. J. and Lee, I. S. 2011. Antioxidant effects of fermented red ginseng extracts in streptozotocin-induced diabetic rats. Ginseng 35, 129-137. https://doi.org/10.5142/jgr.2011.35.2.129
  8. Kim, S. N., Ha, Y. W., Shin, H., Son, S. H., Wu, S. J. and Kim, Y. S. 2007. Simultaneous quantification of 14 ginsenosides in Panax ginseng C.A. Meyer (Korean red ginseng) by HPLC-ELSD and its application to quality control. J. Pharm. Biomed. Anal. 45, 164-170. https://doi.org/10.1016/j.jpba.2007.05.001
  9. Lee, M. H., Lee, B. H., Jung, J. Y., Cheon, D. S., Kim, K. T. and Choi, C. 2011. Antiviral effect of Korean red ginseng extracts and ginsenosides on murine norovirus and feline calicivirus as surrogates for human norovirus. Ginseng 35, 429-435. https://doi.org/10.5142/jgr.2011.35.4.429
  10. Liu, Y., Wang, Q., Yao, X. and Li, Y. 2010. Induction of CYP3A and MDR1 gene expression by baicalin, baicalein, chlorogenic acid, and ginsenoside Rf through constitutive androstane receptor- and pregnane X receptor-mediated pathways. Eur. J. Pharmacol. 640, 46-54. https://doi.org/10.1016/j.ejphar.2010.05.017
  11. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
  12. Markowitz, J. S., Donovan, J. L., DeVane, C. L., Taylor, R. M., Ruan, Y., Wang, J. S. and Chavin, K. D. 2003. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 290, 1500-1504. https://doi.org/10.1001/jama.290.11.1500
  13. Ohkawa, H., Ohishi, N. and Yagi, K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358. https://doi.org/10.1016/0003-2697(79)90738-3
  14. Sohn, E. H, Jang, S. A., Lee, C. H., Jang, K. H., Kang, S. C., Park, H. J. and Pyo, S. 2011. Effects of Korean red ginseng extracts for the treatment of atopic dermatitis-like skin lesions in mice. Ginseng 35, 479-486. https://doi.org/10.5142/jgr.2011.35.4.479
  15. Song, Y. B., An, Y. R., Kim, S. J., Park, H. W., Jung, J. W., Kyung, J. S., Hwang, S. Y. and Kim, Y. S. 2012 Lipid metabolic effect of Korean red ginseng extracts in mice fed on a high-fat diet. J. Sci. Food. Agric. 92, 388-396. https://doi.org/10.1002/jsfa.4589
  16. Sumiyoshi, M., Sakanaka, M. and Kimura, Y. 2010. Effects of Red Ginseng extracts on allergic reactions to food in Balb/c mice. J. Ethnopharmacol. 132, 206-212. https://doi.org/10.1016/j.jep.2010.08.012
  17. Wang, W., Wang, G. J., Xie, H. T., Sun, J. G., Zhao, S., Jiang, X. L., Li, H., Lv, H., Xu, M. J. and Wang, R. 2007. Determination of ginsenoside Rd in dog plasma by liquid chromatography-mass spectrometry after solid-phase extractsion and its application in dog pharmacokinetics studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 852, 8-14. https://doi.org/10.1016/j.jchromb.2006.12.046
  18. Xu, Q. F., Fang, X. L. and Chen, D. F. 2003. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J. Ethnopharmacol. 84, 187-192. https://doi.org/10.1016/S0378-8741(02)00317-3